**Core Concept**
Bupivacaine, ropivacaine, levobupivacaine, and mepivacaine are all long-acting local anesthetics (LAs) used in clinical practice. Cardiotoxicity associated with LAs is primarily due to their ability to block sodium channels in cardiac tissue, leading to abnormal cardiac rhythms and potentially life-threatening arrhythmias.

**Why the Correct Answer is Right**
Among the options listed, bupivacaine is known for its high cardiotoxicity. This is due to its high lipid solubility and rapid onset of action, which allows it to penetrate cardiac tissue quickly. Bupivacaine's cardiotoxic effects are mediated by its ability to block sodium channels in the heart, leading to depolarization of the cardiac myocytes and subsequent arrhythmias. This can progress to severe cardiac complications, including ventricular fibrillation and cardiac arrest.

**Why Each Wrong Option is Incorrect**
* **Option A:** Ropivacaine is a newer long-acting LA that is designed to be less cardiotoxic than bupivacaine. While it still has some potential for cardiotoxicity, it is generally considered safer than bupivacaine.
* **Option B:** Levobupivacaine is the S-enantiomer of bupivacaine and has a lower incidence of cardiotoxicity compared to bupivacaine. However, it is still not considered the safest option.
* **Option D:** Mepivacaine is a short- to intermediate-acting LA that is less cardiotoxic than bupivacaine. It is often used in dental and minor surgical procedures.

**Clinical Pearl / High-Yield Fact**
When using long-acting LAs, it's essential to be aware of their potential for cardiotoxicity, especially in high-risk patients. Bupivacaine is a classic example of a LA that can cause severe cardiac complications, and its use should be carefully monitored.

**Correct Answer: A. Bupivacaine**